Skip to main content
. 2022 Jan 21;17(1):e0262074. doi: 10.1371/journal.pone.0262074

Table 2. Comparison of laboratory parameters in GU and chronic osteoarthritis patients.

GU patients Chronic OA patients MANCOVA Kruskal- Wallis Test
VAS score 0–1 (control) VAS score 0–2 (very mild pain) VAS score ≥ 3 (pain)
F p p
N 14 8 21
Plasma parameters (pg/mL)
    TGF-β1 5108.3 ± 2094.6 1579.7 ± 661.1 739.3 ± 46.5* 4.790 0.015 0.035
    BDNF 3952.0 ± 1106.5 2494.8 ± 1027.4 721.1 ± 211.6*†† 4.896 0.014 0.001
    TNF-α 1.87 ± 0.41 1.51 ± 0.58 1.21 ± 0.11 0.993 0.381 0.488
    IL-8 1.34 ± 0.32 1.39 ± 0.57 2.26 ± 0.45 0.286 0.753 0.251
CSF parameters (pg/mL)
    TGF-β1 38.41 ± 7.85 36.05 ± 10.63 12.16 ± 1.26*# 5.351 0.010 0.008
    BDNF 12.11 ± 4.94 4.18 ± 2.97 1.74 ± 0.55 3.198 0.053 0.104
    TNF-α 0.91 ± 0.34 0.27 ± 0.14 0.83 ± 0.30 0.175 0.840 0.395
    IL-8 74.28 ± 27.46 58.53 ± 28.39 68.05 ± 19.27 0.156 0.856 0.987

GU, genitourinary examination or operation. OA, osteoarthritis. VAS, Visual Analogue Scale. Patients with GU diseases without obvious pain (VAS score 0–1 at rest) were included as a comparison (control) group. Patients with OA were divided into very mild pain (VAS score 0–2) and pain (VAS score ≥ 3) groups according to their level of pain. Data were mean ± S.E. A multivariate analysis of covariance (MANCOVA) adjusted for covariates (age, gender, body mass index, hypertension, diabetes mellitus and pain-relieving drugs used) was used to analyze the data. Data are mean ± SE.

*p < 0.05 vs. GU control patients. And a non-parametric method (Kruskal- Wallis test) was used to analyze the data.

p < 0.05

††p < 0.01 vs. GU control patients.

#p < 0.05 OA with very mild pain vs OA with pain.